Clinical Trial

Concept-verification Clinical Trial on the Inhibition of Breast Cancer Lung Metastasis Progression by Hyperbaric Oxygen

Study acronym: HBOIBCLM
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated April 7, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a proof-of-concept clinical trial focused on exploring whether hyperbaric oxygen therapy (HBOT) can inhibit the progression of lung metastasis in breast cancer patients. Patients enrolled in this arm will receive standard breast cancer treatment combined with HBOT.
Trial Details
NCT Number NCT07514728
Lead Sponsor Jinan Central Hospital
Conditions Breast Cancer, Lung Metastasis, Hyperbaric Oxygen Therapy
Enrollment 10 participants
Start Date 2025-11-24
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-07